Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Lymphoid 350Other hematologic neoplasm 103Dermatologic 89Plasma cell 33Sarcoma 22Myeloid 22Genitourinary 6Classical hematology 5Thoracic 3Gastrointestinal 3Head & Neck 2Gynecologic 2CNS 2Breast 1

Conditions

Ovarian Neoplasms 3160Uterine Cervical Neoplasms 2182Endometrial Neoplasms 1330Breast Neoplasms 816Fallopian Tube Neoplasms 807Carcinoma, Ovarian Epithelial 771Neoplasms 540Colorectal Neoplasms 437Carcinoma, Non-Small-Cell Lung 418Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 353Prostatic Neoplasms 317Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 236Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 224Head and Neck Neoplasms 221Sarcoma 218Carcinoma, Renal Cell 213Recurrence 212Colonic Neoplasms 210Papillomavirus Infections 205Triple Negative Breast Neoplasms 189Squamous Cell Carcinoma of Head and Neck 175Vaginal Neoplasms 147

Interventions

selinexor 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Peripheral × Gynecologic × Clear all
NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

Available
GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

NCT04254107 2025-02-10

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Seagen Inc.

Phase 1 Terminated
133 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡